Methyl 1H-1,2,4-Triazole-3-Carboxylate: Your Trusted Pharmaceutical Intermediate Supplier

Discover the critical role of Methyl 1H-1,2,4-Triazole-3-Carboxylate (CAS 4928-88-5) in synthesizing life-saving antiviral medications like Ribavirin. As a leading manufacturer, we offer high-purity intermediates essential for pharmaceutical production. Learn more about its properties and sourcing from China.

Get a Quote & Sample

Advantages of Sourcing Our Methyl 1H-1,2,4-Triazole-3-Carboxylate

Guaranteed Product Quality

We ensure consistent quality with an assay of ≥98.0% and low loss on drying (≤0.5%), making our product an ideal choice for pharmaceutical companies seeking reliable raw materials for Ribavirin synthesis.

Cost-Effective Pharmaceutical Intermediate

As a direct manufacturer and supplier, we offer competitive pricing for Methyl 1H-1,2,4-Triazole-3-Carboxylate, allowing you to optimize your procurement costs for essential antiviral drug intermediates.

Expertise in Pharmaceutical Synthesis

Our deep understanding of pharmaceutical synthesis allows us to provide Methyl 1H-1,2,4-Triazole-3-Carboxylate that meets stringent industry requirements, supporting your R&D and manufacturing goals for antiviral agents.

Applications of Methyl 1H-1,2,4-Triazole-3-Carboxylate

Ribavirin Manufacturing

This compound is a primary raw material in the synthesis of Ribavirin, a broad-spectrum antiviral drug used to treat various viral infections, demonstrating its critical role in pharmaceutical production.

Antiviral Drug Development

Its unique chemical structure makes it a valuable precursor for developing new antiviral agents and other complex pharmaceutical molecules, driving innovation in healthcare.

Fine Chemical Synthesis

Beyond pharmaceuticals, Methyl 1H-1,2,4-Triazole-3-Carboxylate serves as a versatile building block in the broader field of fine chemical synthesis, offering diverse application potentials.

Research and Development

Scientists and researchers utilize this intermediate for laboratory-scale synthesis and exploration of novel chemical entities, supporting advancement in medicinal chemistry.